IRIS

TARANTINO, GIOVANNI

TARANTINO, GIOVANNI  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE (attivo dal 01/11/1995 al 31/12/2012)  

Mostra records
Risultati 1 - 20 di 132 (tempo di esecuzione: 0.025 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. 1.1 Articolo in rivista 2007 Citro, V.; Milan, G.; Tripodi, F. S.; Gennari, A.; Sorrentino, P.; Gallotta, Giovanni; Postiglione, Alfredo; Tarantino, Giovanni
Exaggerated immune reactions predict the outcome of interferon therapy in patients with chronic hepatitis C. 1.1 Articolo in rivista 2007 Tarantino, Giovanni; Conca, Paolo; Ariello, Manuela; Arena, Adriano
Should nonalcoholic fatty liver disease be regarded as a hepatic illness only? 1.1 Articolo in rivista 2007 Tarantino, Giovanni
Utility of sonography in diagnosing hepatocellular carcinoma 1.1 Articolo in rivista 2007 Tarantino, Giovanni
A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient 1.1 Articolo in rivista 2007 Capone, D.; Palmiero, Giuseppe; Gentile, Antonio; Basile, Vincenzo; Federico, Stefano; Sabbatini, Massimo; Potenza, M.; Perfetti, Anna; Pieri, Maria; Tarantino, Giovanni
From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike? 1.1 Articolo in rivista 2007 Tarantino, Giovanni
Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist? 1.1 Articolo in rivista 2008 Tarantino, Giovanni; Gagliardi, Giuseppe; Conca, Paolo
Circulating levels of interferon-gamma in course of hepatitis C virus-related arthritis. 1.1 Articolo in rivista 2009 Tarantino, Giovanni; Sabatini, P; Soriente, I; Amato, P; Sangiolo, Mg; Riccio, Antonio
Successful lamivudine monotherapy in an elderly patient suffering from HBV-related decompensated cirrhosis associated with widespread leukocytoclastic vasculitis. 1.1 Articolo in rivista 2009 Conca, Paolo; Riccio, Antonio; Tarantino, Giovanni
Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. 1.1 Articolo in rivista 2009 Conca, Paolo; Tarantino, Giovanni
Non-alcoholic fatty liver disease, obesity and other illnesses. 1.1 Articolo in rivista 2008 Tarantino, Giovanni
Could quantitative liver function tests gain wide acceptance among hepatologists? 1.1 Articolo in rivista 2009 Tarantino, Giovanni
Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis. 1.1 Articolo in rivista 2008 Riccio, Antonio; Conca, Paolo; Marzocchella, Carmela; Tarantino, Giovanni
Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. 1.1 Articolo in rivista 2009 Tarantino, Giovanni; Citro, V; Esposito, P; Giaquinto, S; de Leone, A; Milan, G; Tripodi, Fs; Cirillo, Michele; Lobello, Roberto
Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis? 1.1 Articolo in rivista 2006 Tarantino, Giovanni; Conca, Paolo; Ariello, Manuela; Mastrolia, Maria
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study. 1.1 Articolo in rivista 2003 Tarantino, Giovanni; Sorrentino, P; Conca, P; Perrella, A; Ragucci, P; Perrella, O.
A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. 1.1 Articolo in rivista 2007 Tarantino, Giovanni; Conca, Paolo; Basile, Vincenzo; Gentile, Antonio; Capone, D; Polichetti, G; Leo, E.
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. 1.1 Articolo in rivista 2007 Tarantino, Giovanni; Saldalamacchia, Gennaro; Conca, Paolo; Arena, Adriano
Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome. 1.1 Articolo in rivista 2004 Sorrentino, Paolo; Tarantino, Giovanni; Conca, Paolo; Perrella, Alessandro; Perrella, O.
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects. 1.1 Articolo in rivista 2009 Sabbatini, Massimo; Capone, D; Gallo, R; Pisani, Antonio; Polichetti, G; Tarantino, Giovanni; Gentile, A; Rotaia, E; Federico, Stefano